SCHEMBL10126834

SCHEMBL10126834

Cc1cc(N2CCN(C)CC2)c(C)cc1N

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2C P18825 3/20 0.52
MAPT P10636 5/20 0.51
KDM4E B2RXH2 4/20 0.51
GAA P10253 3/20 0.51
PTK2B Q14289 3/20 0.51
MAPK1 P28482 2/20 0.51
HTT P42858 1/20 0.51
RECQL P46063 1/20 0.51
ALDH1A1 P00352 5/20 0.50
POLB P06746 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
RAD52 P43351 1/20 0.46
HSD17B10 Q99714 2/20 0.45
CYP3A4 P08684 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 2/20 0.41
GFER P55789 1/20 0.41
ESR2 Q92731 1/20 0.41
MEN1 O00255 1/20 0.41
THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18341999 0.90 ADRA2C (0.53) ADRA2CMAPTKDM4EGAAPTK2B
SCHEMBL30565922 0.90 ADRA2C (0.53) ADRA2CMAPTKDM4EGAAPTK2B
SCHEMBL30020094 0.84 ALDH1A1 (0.54) ADRA2CMAPTKDM4EGAAPTK2B
SCHEMBL14290947 0.84 KDM4E (0.58) ADRA2CMAPTKDM4EGAAPTK2B
SCHEMBL23153729 0.81 DRD2 (0.50) ADRA2CMAPTKDM4EGAAPTK2B
SCHEMBL17164753 0.81 DRD2 (0.50) ADRA2CMAPTKDM4EGAAPTK2B
SCHEMBL29508932 0.81 DRD2 (0.50) ADRA2CMAPTKDM4EGAAPTK2B
SCHEMBL22861217 0.81 HTR1A (0.45) ADRA2CMAPTKDM4EGAAPTK2B
SCHEMBL19623582 0.79 MAPT (0.52) MAPTKDM4EGAAMAPK1HTT
SCHEMBL15283442 0.77 KDM4E (0.42) ADRA2CMAPTKDM4EGAAPTK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-9487491-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2016-11-08 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-8969336-B2 Diamino heterocyclic carboxamide compound ASTELLAS PHARMA INC. (JP) 2015-03-03 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND ASTELLAS PHARMA INC. (JP) 2014-12-18 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND WATERS TECHNOLOGIES CORPORATION (US) 2012-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140371196-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 ADRA2C 4411/4885MAPT 3116/4885KDM4E 39/4885
US-20120040968-A1 DIAMINO HETEROCYCLIC CARBOXAMIDE COMPOUND EML4, ALK, ERBB4 ADRA2C 4411/4885MAPT 3116/4885KDM4E 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.